Imfinzi (durvalumab) - AstraZeneca
Tecentriq (atezolizumab) - Roche
Avastin (bevacizumab) - Roche
sturlimogene erparepvec (RP2) - Replimune
https://meetings.asco.org/meetings/2026-asco-gastrointestinal-cancers-symposium/333/16884?presentation=255954
 
Richard Kim; Anwaar Saeed; William Chapin; Kevin Kim; Renuka Iyer; Robert Martin II; Axel Grothey; Saikrishna Gadde; Lynn Feun; Afshin Gabayan; Yvonne Saenger; Maen Abdelrahim; Nalini Govada; Ben Xie; May Cho; Adam Burgoyne
 
Dec 2, 2025
 
Next